2026 Q2 Portfolio Activity
In 2026 Q2, Jones Hill Capital LP maintained a portfolio of 41 distinct positions. The most significant new addition was GILEAD SCIENCES INC, now representing 9.21% of the total fund value. They heavily accumulated shares in RELMADA THERAPEUTICS INC, increasing the position by 966.4%. The fund also reduced its exposure to VERTEX PHARMACEUTICALS INC by 89.8%.
Position History
hover any row below to update
Loading…
Jones Hill Capital LP
AUM $470M
Total Positions
41
Quarter
2026 Q2
Top Holding
BMRN (17.4%)
Top 10 Concentration
68.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-41 of 41
Jones Hill Capital LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 17.42% | 15.36% |
#1
Prev: #1
|
8.0 |
—
|
163,200 | 12.9% |
P
S
|
1,431,590 | $81,915,580 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 9.21% | — |
#2
Prev: #—
|
8.7 |
—
|
343,043 | — |
NEW
|
343,043 | $43,340,053 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 6.07% | — |
#3
Prev: #—
|
6.9 |
—
|
1,089,701 | — |
NEW
|
1,089,701 | $28,571,960 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 6.00% | — |
#4
Prev: #—
|
6.4 |
—
|
52,545 | — |
NEW
|
52,545 | $28,214,038 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
BCAX
BICARA THERAPEU...
|
Healthcare | 5.63% | 5.37% |
#5
2
Prev: #7
|
2.8 |
—
|
-367,515 | -29.2% |
P
S
|
892,621 | $26,501,917 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 5.38% | 0.51% |
#6
18
Prev: #24
|
5.2 |
—
|
3,312,323 | 966.4% |
P
S
|
3,655,075 | $25,293,119 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 5.31% | 0.95% |
#7
16
Prev: #23
|
5.1 |
—
|
969,037 | 261.8% |
P
S
|
1,339,212 | $24,976,304 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 4.98% | 1.01% |
#8
14
Prev: #22
|
5.0 |
—
|
510,865 | 305.9% |
P
S
|
677,879 | $23,441,056 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 4.72% | — |
#9
Prev: #—
|
5.4 |
—
|
367,900 | — |
NEW
|
367,900 | $22,206,444 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 4.11% | 5.25% |
#10
2
Prev: #8
|
1.6 |
—
|
-84,783 | -26.6% |
P
S
|
233,808 | $19,354,626 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 3.46% | — |
#11
Prev: #—
|
4.9 |
—
|
512,856 | — |
NEW
|
512,856 | $16,283,178 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 3.41% | 4.76% |
#12
1
Prev: #11
|
1.4 |
—
|
-704,736 | -44.1% |
P
S
|
894,058 | $16,057,282 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
INSM
INSMED INC
|
Healthcare | 2.77% | — |
#13
Prev: #—
|
4.6 |
—
|
122,375 | — |
NEW
|
122,375 | $13,047,622 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 2.58% | 6.61% |
#14
10
Prev: #4
|
1.0 |
—
|
-202,388 | -67.3% |
P
S
|
98,442 | $12,157,587 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 2.15% | 5.93% |
#15
10
Prev: #5
|
0.9 |
—
|
-488,456 | -53.7% |
P
S
|
420,751 | $10,131,684 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 1.98% | — |
#16
Prev: #—
|
4.3 |
—
|
1,759,492 | — |
NEW
|
1,759,492 | $9,307,713 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IMUX
IMMUNIC INC
|
Healthcare | 1.76% | — |
#17
Prev: #—
|
4.2 |
—
|
539,814 | — |
NEW
|
539,814 | $8,296,941 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.72% | — |
#18
Prev: #—
|
4.2 |
—
|
747,313 | — |
NEW
|
747,313 | $8,093,400 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TNXP
TONIX PHARMACEU...
|
Healthcare | 1.70% | 1.33% |
#19
Prev: #19
|
3.2 |
—
|
173,312 | 38.3% |
P
S
|
625,428 | $7,980,461 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 1.58% | — |
#20
Prev: #—
|
4.1 |
—
|
340,000 | — |
NEW
|
340,000 | $7,432,400 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 1.53% | — |
#21
Prev: #—
|
4.1 |
—
|
574,166 | — |
NEW
|
574,166 | $7,182,817 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 1.43% | 2.30% |
#22
8
Prev: #14
|
0.6 |
—
|
-539,000 | -45.0% |
P
S
|
659,213 | $6,717,380 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 1.30% | — |
#23
Prev: #—
|
4.0 |
—
|
653,572 | — |
NEW
|
653,572 | $6,130,505 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.18% | — |
#24
Prev: #—
|
4.0 |
—
|
57,100 | — |
NEW
|
57,100 | $5,566,108 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 1.17% | 10.40% |
#25
23
Prev: #2
|
0.5 |
—
|
-97,480 | -89.8% |
P
S
|
11,123 | $5,525,128 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.54% | 4.98% |
#26
16
Prev: #10
|
0.2 |
—
|
-543,190 | -91.6% |
P
S
|
49,850 | $2,529,888 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.46% | 1.04% |
#27
7
Prev: #20
|
0.2 |
—
|
-60,026 | -59.7% |
P
S
|
40,567 | $2,177,231 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 0.37% | — |
#28
Prev: #—
|
3.6 |
—
|
161,486 | — |
NEW
|
161,486 | $1,752,123 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 0.04% | — |
#29
Prev: #—
|
3.5 |
—
|
26,760 | — |
NEW
|
26,760 | $174,743 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 0.00% | 0.23% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-45,809 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 0.00% | 0.34% |
Sold All 😨
(Was: #25) |
0.0 |
—
|
-301,604 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TRDA
ENTRADA THERAPE...
|
Healthcare | 0.00% | 1.01% |
Sold All 😨
(Was: #21) |
0.0 |
—
|
-374,010 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MANE
VERADERMICS INC
|
Healthcare | 0.00% | 1.37% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-100,843 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 0.00% | 1.44% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-513,053 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 0.00% | 1.48% |
Sold All 😨
(Was: #16) |
0.0 |
—
|
-140,843 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 0.00% | 2.19% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-2,383,031 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.00% | 2.91% |
Sold All 😨
(Was: #13) |
0.0 |
—
|
-1,771,926 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARGX
ARGENX SE
|
Healthcare | 0.00% | 4.07% |
Sold All 😨
(Was: #12) |
0.0 |
—
|
-25,995 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 5.23% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-1,165,557 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 0.00% | 5.89% |
Sold All 😨
(Was: #6) |
0.0 |
—
|
-521,237 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 0.00% | 8.03% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-644,831 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-41 of 41 holdings